![]() |
市場調査レポート
商品コード
1739466
ポリグリコール酸市場:フォームタイプ別、エンドユーザー別、地域別、2026-2032年Polyglycolic Acid Market By Form Type (Fibers, Films,), End-User (Medical, Oil & Gas, Packaging), & Region for 2026-2032 |
||||||
|
ポリグリコール酸市場:フォームタイプ別、エンドユーザー別、地域別、2026-2032年 |
出版日: 2025年05月08日
発行: Verified Market Research
ページ情報: 英文 202 Pages
納期: 2~3営業日
|
プラスチック廃棄物の削減と環境への影響の低減が重視されるようになった結果、PGAの研究と生産への投資が増加し、市場成長を牽引し、2024年には52億米ドルを超え、2032年までに106億6,000万米ドルに達すると予想されています。
世界中の産業、特に包装、医療機器、石油・ガス分野では、従来のポリマーに代わる環境に優しい代替品を求めており、PGAの生分解性と優れた機械的特性は魅力的な選択肢となっています。医療分野では、生体吸収性縫合糸、組織工学、ドラッグデリバリーシステムでPGAの使用が増加しており、2026年から2032年までのCAGRは約9.40%で成長すると予想されます。
ポリグリコール酸市場定義/概要
ポリグリコール酸(PGA)は、高い強度と加水分解安定性を持つ生分解性熱可塑性ポリマーです。生体適合性が高く、体内で安全に分解されるため、生体吸収性縫合糸、組織工学、ドラッグデリバリーシステムなどの医療用途で一般的に使用されています。PGAはまた、堆肥化可能な材料を製造する包装産業や、生分解性ツールを製造する石油・ガス分野でも使用されています。PGAの将来は有望で、さまざまな業界で持続可能で環境に優しい素材に対する需要が高まっており、PGAの応用におけるさらなる研究と革新が推進されています。
プラスチック廃棄物の削減が重視されるようになり、ポリグリコール酸(PGA)のような持続可能な代替材料への需要が高まっています。PGAは、医療機器、包装、農業などの産業で使用される生分解性ポリマーです。世界中の政府や団体は、プラスチック廃棄物を制限する政策をますます提唱しており、PGAが従来のプラスチックに取って代わる機会を提示しています。例えば、欧州連合(EU)は2023年6月、使い捨てプラスチックに対する規制を強化し、PGAのような生分解性代替品への移行を企業に促しています。この規制圧力は、PGA市場の成長を促す大きな要因となっています。
さらに、政府の取り組みもPGA市場に利益をもたらしています。2024年7月、米国政府はPGAを含む生分解性プラスチックの開発を支援する1億米ドルの資金援助プログラムを発表しました。このイニシアティブは、プラスチック汚染を削減し、循環型経済を促進するための大きな取り組みの一環です。このような政府の支援は、PGA分野の研究開発を加速させるだけでなく、企業が技術革新を行い、生産を拡大するための経済的インセンティブも提供します。その結果、PGA市場は、規制による圧力と民間・公的部門からの投資増加の両方によって、今後数年間で大幅に拡大すると予想されます。
原材料コストの変動は、ポリグリコール酸(PGA)市場の成長にとって大きな障壁です。PGAの生産は、グリコリドやその他の化学物質といった特定の原材料に依存しており、これらはサプライチェーンの混乱、地政学的緊張、関連産業における需要の変動などによって価格が変動しやすいです。これらの原材料のコストが上昇すると、PGAの生産コスト全体に直接影響を及ぼし、他の生分解性ポリマーや従来のプラスチックと比較して競争力が低下します。価格変動は、メーカーがPGA生産への投資を躊躇させ、PGAベースの製品の市場導入を遅らせる可能性があります。
さらに、原料価格の変動による生産コストの高騰は、PGAメーカーが安定した利益率を維持することを困難にします。特に包装や農業のようなコストに敏感な産業では、コスト効率が普及に不可欠な市場において、競争力のある価格の製品を提供できないことが、市場の成長を阻害する可能性があります。主要企業は、市場シェアを失うことなくコスト増を顧客に転嫁するのに苦労し、PGAの生産や技術革新への投資が減少する可能性があります。その結果、変動する原料コストはPGA市場に不確実性をもたらし、成長を鈍化させ、持続可能な素材に対する需要の高まりを活用する能力を制限する可能性があります。
The growing emphasis on reducing plastic waste and environmental impact has resulted in increased investment in PGA research and production, which is driving market growth is surpassing USD 5.2 Billion in 2024 and reaching USD 10.66 Billion by 2032.
As industries around the world, particularly in packaging, medical devices, and the oil and gas sector, seek environmentally friendly alternatives to traditional polymers, PGA's biodegradability and excellent mechanical properties make it an appealing option. In the medical field, the increasing use of PGA in bioresorbable sutures, tissue engineering, and drug delivery systems is expected to grow at a CAGR of about 9.40% from 2026 to 2032.
Polyglycolic Acid Market: Definition/ Overview
Polyglycolic Acid (PGA) is a biodegradable thermoplastic polymer with high strength and hydrolytic stability. It is commonly used in medical applications such as bioresorbable sutures, tissue engineering, and drug delivery systems due to its biocompatibility and ability to degrade safely within the body. PGA is also used in the packaging industry to produce compostable materials, as well as in the oil and gas sector to create biodegradable tools. The future of PGA looks promising, with rising demand for sustainable and eco-friendly materials in a variety of industries, driving additional research and innovation in its applications.
The growing emphasis on reducing plastic waste is increasing demand for sustainable alternatives such as polyglycolic acid (PGA). PGA is a biodegradable polymer used in industries such as medical devices, packaging, and agriculture. Governments and organizations around the world are increasingly advocating for policies that limit plastic waste, presenting opportunities for PGA to replace traditional plastics. For instance, in June 2023, the European Union imposed stricter regulations on single-use plastics, encouraging businesses to shift to biodegradable alternatives such as PGA. This regulatory pressure is a significant factor driving the growth of the PGA market.
Furthermore, government initiatives are benefiting the PGA market. In July 2024, the US government announced a $100 million funding program to support the development of biodegradable plastics, including PGA. This initiative is part of a larger effort to reduce plastic pollution and encourage circular economies. Such government assistance not only accelerates research and development in the PGA sector, but also provides a financial incentive for businesses to innovate and expand production. As a result, the PGA market is expected to expand significantly in the coming years, driven by both regulatory pressures and increased investment from the private and public sectors.
Fluctuating raw material costs are a significant barrier to the growth of the polyglycolic acid (PGA) market. The production of PGA is dependent on specific raw materials, such as glycolide and other chemicals, which are subject to price volatility due to supply chain disruptions, geopolitical tensions, and fluctuating demand in related industries. When the costs of these raw materials rise, it has a direct impact on PGA's overall production costs, making it less competitive in comparison to other biodegradable polymers and conventional plastics. Price volatility can deter manufacturers from investing in PGA production, slowing market adoption of PGA-based products.
Furthermore, high production costs due to raw material price fluctuations can make it difficult for PGA producers to maintain consistent profit margins. In a market where cost-efficiency is critical for widespread adoption, particularly in cost-sensitive industries such as packaging and agriculture, the inability to offer competitively priced products can stymie market growth. Companies may struggle to pass on the increased costs to customers without losing market share, potentially leading to less investment in PGA production and innovation. As a result, fluctuating raw material costs cause uncertainty in the PGA market, potentially slowing growth and limiting its ability to capitalize on rising demand for sustainable materials.
The fibers is a dominating segment in the polyglycolic acid (PGA) market. PGA fibers are in high demand, particularly in the medical field, due to their superior biodegradability, strength, and compatibility with human tissue. These fibers are widely used in absorbable sutures, which are essential for minimally invasive procedures and wound care. The medical industry's growing emphasis on advanced, biodegradable materials is fueling this demand. For instance, in July 2024, a healthcare company announced that it would increase PGA fiber production to meet rising demand for medical sutures and other biodegradable products. This expansion reflects the critical role that PGA fibers play in modern medical applications, driving the market forward.
Furthermore, demand for PGA fibers is expanding beyond the medical sector to include areas such as textiles and packaging, where sustainability is becoming increasingly important. Governments and organizations are promoting environmentally friendly materials, and PGA fibers provide a viable alternative. In April 2024, the Japanese government issued new regulations promoting the use of biodegradable fibers in consumer goods, which are expected to significantly increase the adoption of PGA fibers in a variety of industries. This regulatory support, combined with an increasing preference for sustainable materials, is expected to drive rapid growth in the PGA fibers segment, thereby fueling the overall polyglycolic acid market.
The film segment is the second fastest growing form type. PGA films are becoming increasingly popular in packaging and environmental applications due to their biodegradability and barrier properties, making them an appealing alternative to traditional plastic films. The growing interest in sustainable packaging solutions is fueling the films segment's rapid growth.
The rising demand from the medical sector is a significant driver of growth in the polyglycolic acid (PGA) market. PGA is highly valued in the medical field due to its biodegradability and biocompatibility, making it suitable for absorbable sutures, tissue engineering, and drug delivery systems. The increasing prevalence of minimally invasive surgeries, as well as the growing emphasis on advanced wound care, are driving up demand for PGA-based products. For instance, in June 2024, the US Food and Drug Administration (FDA) approved a new PGA-based surgical mesh developed by a leading medical device company, indicating that PGA's use in the medical sector will continue to grow. This approval highlights the ongoing trend of using PGA for innovative medical solutions, which is driving market growth.
Furthermore, government initiatives and healthcare investments are promoting the expansion of PGA in the medical industry. In March 2024, The European Union launched a funding program to accelerate the development of biodegradable medical materials, including PGA, as part of its overall strategy to promote sustainable healthcare solutions. This program not only promotes PGA research and development, but it also helps to accelerate the commercialization of PGA-based medical products.
The packaging segment is the second fastest-growing end user. The shift toward environmentally friendly packaging solutions is accelerating the use of PGA films, resulting in rapid growth in this segment.
Country/Region-wise
The growing demand in the medical and packaging industries in North America is a major driver of the polyglycolic acid (PGA) market. In the medical field, PGA's biodegradability and biocompatibility make it an ideal material for a variety of applications such as bioresorbable sutures, tissue engineering scaffolds, and drug delivery systems. The increasing emphasis on advanced medical treatments and minimally invasive procedures in the United States and Canada is driving the adoption of PGA-based products. In July 2024, a leading US medical device company announced that it would expand its product line to include PGA-based bioresorbable implants, citing increased demand for safer and more effective surgical materials.
Consumer preferences and regulatory pressures are driving a significant shift in the North American packaging industry to sustainable and environmentally friendly materials. PGA's compostability and strength make it an appealing alternative to traditional plastics in a variety of packaging applications. In June 2024, North American packaging company introduced a new line of compostable packaging solutions incorporating PGA in response to the growing demand for environmentally friendly packaging options. These developments, combined with government initiatives promoting the use of biodegradable materials, are expected to lead to the dominance of North America in this market.
The growing use of biodegradable materials in the Asia-Pacific region is expected to significantly boost the polyglycolic acid (PGA) market. As countries in the region, including China, Japan, and India, focus more on sustainability and reducing environmental impact, there is a growing preference for eco-friendly materials such as PGA. These countries' governments are enacting stricter plastic-use regulations while also encouraging the development and adoption of biodegradable alternatives. For instance, in July 2024, China implemented new policies aimed at reducing plastic waste, driving up demand for biodegradable polymers such as PGA in packaging and consumer goods.
Furthermore, the industrial and healthcare sectors in Asia-Pacific are rapidly expanding, increasing the demand for advanced materials. PGA's unique properties, such as biodegradability and high strength, make it an excellent choice for a wide range of applications, including bioresorbable medical devices and compostable packaging. Recent developments in the region have emphasized this trend. In August 2024, a Japanese packaging company announced plans to increase production of biodegradable packaging materials, including PGA-based products, in response to rising demand. This increased emphasis on sustainable solutions is expected to significantly boost the PGA market in Asia-Pacific, making it one of the most dynamic regions for market growth.
The competitive landscape of the polyglycolic acid (PGA) market is shaped by a mix of emerging players, regional manufacturers, and companies focusing on niche applications. These players are leveraging advancements in biocompatible and biodegradable materials to cater to industries such as medical devices, packaging, and oil & gas. The market is seeing increased competition in developing cost-effective production methods and expanding the application range of PGA. Additionally, collaborations and partnerships with research institutions and companies in adjacent industries are becoming common strategies to enhance market presence and innovation in this space.
Some of the prominent players operating in the polyglycolic acid market include:
Kureha Corporation
Corbion
Shenzhen Polymtek Biomaterial Co, Ltd.
BMG Incorporated
Huizhou Foryou Medical Devices Co., Ltd.
In July 2024, Medtronic has made significant investments in research and development of PGA-based medical devices. The company is focusing on using PGA's biocompatibility to develop innovative surgical sutures and tissue engineering applications.
In August 2024, BASF has announced an expansion of its PGA production facility in Ludwigshafen, Germany. The expansion is intended to increase the company's capacity to meet growing demand for PGA in medical applications and biodegradable materials.
In May 2024, Stryker has introduced a new line of surgical products made from PGA, including advanced sutures and fixation devices. These products aim to improve performance and biocompatibility in a variety of surgical procedures.